skip to main content

    Updated Visitor Guidelines

 

MENU

 

Personal Growth After Cancer

Jeff Smith's prostate cancer diagnosis changed his perspective on life. After his treatment ended, he decided to leave behind all of those aspects of his life he didn’t love and start a new journey based on human connections.

The Transition From Patient to Survivor

The transition from cancer patient to cancer survivor is an occasion to celebrate, but also comes with questions and uncertainty. As more patients survive cancer, the health care field faces a new challenge: How to best manage the ongoing care of cancer survivors.

Immune response prognostic for prostate cancer survival, recurrence and response to radiation therapy

A new study finds that immune response in prostate cancer may be able to forecast how patients will respond to radiation therapy, as well as their likelihood of disease recurrence and survival outcomes.

Interactive web tool shows potential impact of tobacco policies

Tobacco Control Policy (TCP) tool is a simulation model and web-based tool, hosted at the U-M School of Public Health, which can help predict the potential state-by-state impact of changing policies, such as raising cigarette taxes, implementing smoke-free air laws and increasing tobacco control expenditures on deaths avoided and years of life gained.

New Compound Shows Potential for Triple-Negative Breast Cancer

An investigation from the University of Michigan could eventually lead to new therapies that take aim at the most aggressive type of breast cancer -- triple-negative.

Gaming Cells to Turn Off the Metastases Switch in Breast Cancer

Author: Rosemary Clandos  Media contact: Nicole Fawcett, 734-764-2220 |  Patients may contact Cancer AnswerLine™,  800-865-1125

Researchers Find Drug Combo Effective Against Triple-Negative Breast Cancer

In the hunt for novel treatments against an aggressive form of breast cancer, University of Michigan researchers recently combined a new protein inhibitor with a chemotherapy drug.

Labyrinth chip could help monitor aggressive cancer stem cells

A new chip etched with fluid channels sends blood samples through a hydrodynamic maze to separate out rare circulating cancer cells into a relatively clean stream for analysis. It is already in use in a breast cancer clinical trial.

Pages